Watch
NewsCoronavirus

Actions

Remdesivir has 'little or no effect' in treating severe COVID-19 cases, WHO says

Agency says 3 other drugs also have no effect
items.[0].image.alt
MTVA - Media Service Support and Asset Management Fund
Zsolt Czegledi/AP
A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, Thursday Oct. 15, 2020. The drug developed by the Budapest based Chemical Works of Gedeon Richter Plc., is administered to novel coronavirus patients in serious condition as a clinical test to stop the replication of the virus. (Zsolt Czegledi/MTI via AP)
Remdesivir has 'little or no effect' in treating severe COVID-19 cases, WHO says
Posted at 6:20 AM, Oct 16, 2020
and last updated 2020-10-16 09:20:46-04

GENEVA — The U.N. health agency says the world’s largest randomized trial of COVID-19 treatments found “conclusive evidence” that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has little or no effect on severe cases.

The World Health Organization has announced long-awaited results of its six-month “Solidarity Therapeutics Trial” that endeavored to see if existing drugs might have an effect on the coronavirus.

The study, which was not peer-reviewed, found that four treatments tested — remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon — had “ little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.”

Remdesivir was the only drug of the four that had not largely been ruled out as ineffective in fighting COVID-19.

Copyright 2020 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Submit Your Back to School Photo!

Submit Your Back to School Photo!